Protein kinase C alpha-mediated negative feedback regulation is responsible for the termination of insulin-like growth factor I-induced activation ofnuclear phospholipase C beta 1 in Swiss 3T3 cells
Am. Xu et al., Protein kinase C alpha-mediated negative feedback regulation is responsible for the termination of insulin-like growth factor I-induced activation ofnuclear phospholipase C beta 1 in Swiss 3T3 cells, J BIOL CHEM, 276(18), 2001, pp. 14980-14986
Previous studies from several independent laboratories have demonstrated th
e existence of an autonomous phosphoinositide (PI) cycle within the nucleus
, where it is involved in both cell proliferation and differentiation. Stim
ulation of Swiss 3T3 cells with insulin-like growth factor-I (IGF-I) has be
en shown to induce a transient and rapid increase in the activity of nuclea
r-localized phospholipase C (PLC) beta1, which in turn leads to the product
ion of inositol trisphosphate and diacylglycerol in the nucleus. Nuclear di
acylglycerol provides the driving force for the nuclear translocation of pr
otein kinase C (PKC) alpha. Here, we report that treatment of Swiss 3T3 cel
ls with Go6976, a selective inhibitor of PKC alpha, caused a sustained elev
ation of IGF-I-stimulated nuclear PLC activity. A time course study reveale
d an inverse relationship between nuclear PKC activity and the activity of
nuclear PLC in IGF-I-treated cells. A time-dependent association between PK
C alpha and PLC beta1 in the nucleus was also observed following IGF-I trea
tment. Two-dimensional phosphopeptide mapping and site-directed mutagenesis
demonstrated that PKC promoted phosphorylation of PLC beta1 at serine 887
in the nucleus of IGF-I-treated cells. Overexpression of either a PLC beta1
mutant in which the PKC phosphorylation site Ser(887) was replaced by alan
ine, or a dominant-negative PKC alpha, resulted in a sustained activation o
f nuclear PLC following IGF-I stimulation. These results indicate that a ne
gative feedback regulation of PLC beta1 by PKC a plays a critical role in t
he termination of the IGF-I-dependent signal that activates the nuclear PI
cycle.